ASCO 2015: ( DCTH ) Delcath Systems Shows Life-Extending Results Treating Liver Cancer Patients
By The ASCO Post
Posted: 5/31/2015 7:50:52 PM
Clinicians continue to produce positive, life-extending results treating liver cancer patients with CHEMOSAT in multiple tumor types
CHEMOSAT is well tolerated and is an easy-to-learn procedure for an experienced treatment team
Multiple treatment courses of at least four procedures have been shown to be safe and well tolerated while continuing to provide clinical benefit and good quality of life
Reimbursement continues to be covered through individual funding requests Clinicians are encouragedby the potential for CHEMOSAT to treat many tumor types and support the generation of additional data in these potential indications.